Discover the 2023 Immune Tolerance Landscape Review

A comprehensive analysis of the drug and trial landscape and updates from 2023, key regulatory announcements from around the globe, and what the future holds for the Immune Tolerance landscape.

Download Here

About the 2023 Landscape Review

Explore the 2023 landscape of Immune Tolerance drugs with an in-depth analysis covering mechanisms of action, drug status, prominent targets, and key developers. The dynamic field of Beacon Immune Tolerance is rapidly evolving, specifically focusing on inflammatory bowel disease, rheumatoid arthritis, and multiple sclerosis.
Diversification in mechanisms of action is evident, with a rising trend in immune tolerance therapies marking a departure from the extensively studied approach of immunosuppression.

Delve into the 2023 Immune Tolerance trial landscape, offering insights into the leading clinical diseases under investigation. Uncover trial initiation and completion dates throughout 2023, along with H2 2023 terminations and regulatory announcements. Interest in targeting cytokines persists, and the exploration of cell therapies gains momentum. Additionally, modalities such as protein degraders, though currently representing a small fraction of the landscape, are attracting attention. The potential for groundbreaking developments in this space continually expands, with promising novel activities on the horizon.

You may also be interested in...

2023 Gene Therapy Landscape Review

Find out more

The 2023 RNA Landscape Review

Find out more

2023 Cell Therapy Landscape Review

Find out more

2023 Immune Tolerance Landscape Review

Find out more

Monoclonal Antibodies (mAbs) Unveiled: A Comprehensive Review of the Landscape in Immune-Mediated Diseases Report 2023

Find out more

Allergies Report 2023

Find out more

Find out more

Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

Each dataset features proprietary, hyper-relevant search and filtering tailored to specific modalities, in-depth data, plus additional market insight curated by our subject matter experts. Beacon is here to support you in making these decisions with confidence through our encompassing database solution.

With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.


Discover more about Beacon

Any questions? Get in touch

Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.




 Get Started